SEC Form D · filed October 14, 2022
INVIVO THERAPEUTICS HOLDINGS CORP
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Richard Toselli · Cambridge, MAExec · DirectorSarah Tavel · New York, NYDirectorTerry D. Borst · Atascadero, CADirectorJuan M. Hill · Waltham, MAExecSteven T. Berg · Waltham, MADirectorRobert A. Rosenthal · Cambridge, MADirectorShaheed Bailey · Clifton, NJDirectorCary G. Marr · George Town, Grand Cayman, Cayman IslandsDirectorRichard Christopher · Cambridge, MAExecHeather A. Hamel · Cambridge, MAExecMatthew B. Ruesch · McLean, VADirectorHeather A. Hamel · Cambridge, MAExecRichard A. Roberts · Cambridge, MADirectorStalin Ramirez · Fair Lawn, NJExec · DirectorDaniel A. Marshak · Cambridge, MADirectorPortage Ventures III GP Inc · Toronto, Ontario, CanadaDirectorClaudio D. Ruben · Santa Fe, NMDirectorJoshua T. Weisenbeck · New York, NYDirectorC. A. Merrifield · Cambridge, MADirectorMichael Vela · Chesterfield, MODirectorChristina A. Morrison · Cambridge, MADirectorJeff Smith · Chesterfield, MOExecBrandon T. Brahm · New York, NYExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗